Eupraxia Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Eupraxia Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Eupraxia Pharmaceuticals Inc
Rating: 1.66641675
Author: Trendlyne DVM scores

about

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosi...

8.67 0.01 (0.12%)

223.51% Gain from 52W Low

3,682

XNAS Volume

XNAS 29 Jan, 2026 10:15 AM (EST)

Not Eligible

Expensive Valuation

3.7 / 100

Technically Moderately Bullish

63.0 / 100

No estimates available

Eupraxia Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Eupraxia Pharma Inc Live Stock Price Today, Share Analysis and Chart

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosi...

223.51% Gain from 52W Low

SWOT Analysis

Eupraxia Pharma Inc Live Price Chart